Myriad Genetics Forms Strategic Partnership with Illumina in Oncology
Go back to Myriad Genetics Forms Strategic Partnership with Illumina in Oncology| Illumina, Inc. (NASDAQ: ILMN) | Delayed: 219.40 +6.16 (2.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $213.24 | 52 Week High | $196.47 | |||
| Open | $212.40 | 52 Week Low | $127.10 | |||
| Day High | $220.43 | P/E | 243.78 | |||
| Day Low | $208.50 | EPS | $0.90 | |||
| Volume | 1,917,213 | |||||
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.20 -0.02 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.22 | 52 Week High | $45.34 | |||
| Open | $3.22 | 52 Week Low | $15.92 | |||
| Day High | $3.26 | P/E | 1.37 | |||
| Day Low | $3.12 | EPS | $2.33 | |||
| Volume | 1,279,043 | |||||
